🇺🇸
United States · US · US:72237-103_5e9b366c-3fc4-4178-bb80-687e21f9beff
XPOVIO
Orange BookUNIISPLATC L01XX66
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerKaryopharm Therapeutics Inc.
CountryUS (United States)
ATC codeL01XX66
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1172237103054 BLISTER PACK in 1 CARTON (72237-103-05) / 2 TABLET, FILM COATED in 1 BLISTER PACK (72237-103-15)
Annotations
UNII (FDA Substance ID)
31TZ62FO8F
SELINEXOR
RxCUI 2178390
Orange Book
N212306
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "31TZ62FO8F",
"rxcui": "2178390",
"inchikey": "DEVSOMFAQLZNKR-RJRFIUFISA-N",
"display_name": "SELINEXOR",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"f6dd2682-75a6-4863-90a8-a3197f6f78a8": {
"match": "brand_token",
"title": "XPOVIO (SELINEXOR) TABLET, FILM COATED [KARYOPHARM THERAPEUTICS INC.]",
"spl_version": "18",
"published_date": "2026-05-13"
}
},
"productid": "72237-103_5e9b366c-3fc4-4178-bb80-687e21f9beff",
"productndc": "72237-103",
"dosage_form": "TABLET, FILM COATED",
"orange_book": {
"appl_no": "212306",
"products": [
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "20MG",
"product_no": "001",
"approval_date": "Jul 3, 2019"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "40MG",
"product_no": "002",
"approval_date": "Apr 15, 2021"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "50MG",
"product_no": "003",
"approval_date": "Apr 15, 2021"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "60MG",
"product_no": "004",
"approval_date": "Apr 15, 2021"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "10MG",
"product_no": "005",
"approval_date": "Mar 10, 2025"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "80MG",
"product_no": "006",
"approval_date": "Oct 20, 2025"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "SELINEXOR",
"proprietary_name": "XPOVIO",
"active_ingred_unit": "mg/1",
"application_number": "NDA212306",
"marketing_category": "NDA",
"nonproprietary_name": "selinexor",
"start_marketing_date": "20210519",
"active_numerator_strength": "50"
}Related drugs
Other records sharing ATC code L01XX66.
- 🇨🇭Nexpovio
- CZNEXPOVIOStemline Therapeutics B.V., Amsterdam
- ISNEXPOVIOStemline Therapeutics B.V.
- PLNEXPOVIOStemline Therapeutics B.V.
- DKNEXPOVIOStemline Therapeutics B.V.
- CZNEXPOVIOStemline Therapeutics B.V., Amsterdam
- CZNEXPOVIOStemline Therapeutics B.V., Amsterdam
- CZNEXPOVIOStemline Therapeutics B.V., Amsterdam
Access this data programmatically
Query XPOVIO and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.